SARS-CoV-2 : methods and protocols /
| Other Authors: | , , |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
New York :
Humana Press,
[2022]
|
| Series: | Methods in molecular biology (Clifton, N.J.),
|
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book. |
Table of Contents:
- Evolution and Epidemiology of SARS-CoV-2 Virus
- Molecular Epidemiology of SARS-CoV-2 by Sequencing
- Advanced Genetic Methodologies in Tracking Evolution and Spread of SARS-CoV-2
- Antigen-Based Point of Care Testing (POCT) for Diagnosing SARS-CoV-2: Assessing Performance
- Diagnostic Method for COVID-19 Using Sugar Chain-Immobilized Nanoparticles and Saliva Specimens
- Detection and Quantification of SARS-CoV-2 by Real-Time RT-PCR Assay
- Immunofluorescent Antibody Techniques in the Diagnosis of SARS-CoV-2 Infection in Humans
- Propagation and Quantification of SARS-CoV-2
- Quantification of Infectious SARS‐CoV‐2 by the 50% Tissue Culture Infectious Dose Endpoint Dilution Assay
- One-Step Reverse Transcription Droplet Digital PCR Protocols for SARS-CoV-2 Detection and Quantification
- Profiling SARS-CoV-2 Infection by High-Throughput Shotgun Proteomics
- Detection of SARS-CoV-2 by Mass Spectrometry
- Bioinformatics-Based Approaches to Study Virus–Host Interactions During SARS-CoV-2 Infection
- Human Nasal Epithelial Cells (hNECs) Generated by Air-Liquid Interface (ALI) Culture as a Model System for Studying the Pathogenesis of SARS-CoV-2
- Animal Models of COVID-19: Nonhuman Primates
- Animal Models of COVID-19: Transgenic Mouse Model
- Immunohistochemical Detection of SARS-CoV-2 Antigens, by Single and Multiple Immunohistochemistry
- Measuring Neutralizing Antibodies to SARS-CoV-2 Using Lentiviral Spike-Pseudoviruses
- Antiviral Strategies Against SARS-CoV-2: A Systems Biology Approach
- Neutralization Assay for SARS-CoV-2 Infection: Plaque Reduction Neutralization Test
- Pseudovirus-Based Assays for the Measurement of Antibody-Mediated Neutralization of SARS-CoV-2
- Cytopathic Effect (CPE)-Based Drug Screening Assay for SARS-CoV-2
- Strengthening Biorisk Management in Research Laboratories with Security-Sensitive Biological Agents like SARS-CoV-2
- Biorisk Management for SARS-CoV-2 Research in a Biosafety Level-3 Core Facility
- Methods of SARS-CoV-2 Inactivation.